FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2942881430> ?p ?o ?g. }

• W2942881430 endingPage "e1002794" @default.
• W2942881430 startingPage "e1002794" @default.
• W2942881430 abstract "Background Accurate, comprehensive, and timely detection of drug-resistant tuberculosis (TB) is essential to inform patient treatment and enable public health surveillance. This is crucial for effective control of TB globally. Whole-genome sequencing (WGS) and targeted next-generation sequencing (NGS) approaches have potential as rapid in vitro diagnostics (IVDs), but the complexity of workflows, interpretation of results, high costs, and vulnerability of instrumentation have been barriers to broad uptake outside of reference laboratories, especially in low- and middle-income countries. A new, solid-state, tabletop sequencing instrument, Illumina iSeq100, has the potential to decentralize NGS for individual patient care.Methods and findings In this study, we evaluated WGS and targeted NGS for TB on both the new iSeq100 and the widely used MiSeq (both manufactured by Illumina) and compared sequencing performance, costs, and usability. We utilized DNA libraries produced from Mycobacterium tuberculosis clinical isolates for the evaluation. We conducted WGS on three strains and observed equivalent uniform genome coverage with both platforms and found the depth of coverage obtained was consistent with the expected data output. Utilizing the standardized, cloud-based ReSeqTB bioinformatics pipeline for variant analysis, we found the two platforms to have 94.0% (CI 93.1%–94.8%) agreement, in comparison to 97.6% (CI 97%–98.1%) agreement for the same libraries on two MiSeq instruments. For the targeted NGS approach, 46 M. tuberculosis–specific amplicon libraries had 99.6% (CI 98.0%–99.9%) agreement between the iSeq100 and MiSeq data sets in drug resistance–associated SNPs. The upfront capital costs are almost 5-fold lower for the iSeq100 ($19,900 USD) platform in comparison to the MiSeq ($99,000 USD); however, because of difference in the batching capabilities, the price per sample for WGS was higher on the iSeq100. For WGS of M. tuberculosis at the minimum depth of coverage of 30x, the cost per sample on the iSeq100 was $69.44 USD versus $28.21 USD on the MiSeq, assuming a 2 × 150 bp run on a v3 kit. In terms of ease of use, the sequencing workflow of iSeq100 has been optimized to only require 27 minutes total of hands-on time pre- and post-run, and the maintenance is simplified by a single-use cartridge–based fluidic system. As these are the first sequencing attempts on the iSeq100 for M. tuberculosis, the sequencing pool loading concentration still needs optimization, which will affect sequencing error and depth of coverage. Additionally, the costs are based on current equipment and reagent costs, which are subject to change.Conclusions The iSeq100 instrument is capable of running existing TB WGS and targeted NGS library preparations with comparable accuracy to the MiSeq. The iSeq100 has reduced sequencing workflow hands-on time and is able to deliver sequencing results in <24 hours. Reduced capital and maintenance costs and lower-throughput capabilities also give the iSeq100 an advantage over MiSeq in settings of individualized care but not in high-throughput settings such as reference laboratories, where sample batching can be optimized to minimize cost at the expense of workflow complexity and time." @default.
• W2942881430 created "2019-05-09" @default.
• W2942881430 creator A5008722114 @default.
• W2942881430 creator A5014662243 @default.
• W2942881430 creator A5018647179 @default.
• W2942881430 creator A5022367224 @default.
• W2942881430 creator A5029873317 @default.
• W2942881430 creator A5045341602 @default.
• W2942881430 creator A5062721329 @default.
• W2942881430 creator A5066953701 @default.
• W2942881430 creator A5068234468 @default.
• W2942881430 creator A5071641093 @default.
• W2942881430 creator A5087168986 @default.
• W2942881430 creator A5090314881 @default.
• W2942881430 date "2019-04-30" @default.
• W2942881430 modified "2023-10-17" @default.
• W2942881430 title "Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation" @default.
• W2942881430 cites W1211915768 @default.
• W2942881430 cites W2103673802 @default.
• W2942881430 cites W2150860868 @default.
• W2942881430 cites W2400129586 @default.
• W2942881430 cites W2537365661 @default.
• W2942881430 cites W2542571239 @default.
• W2942881430 cites W2775071020 @default.
• W2942881430 cites W2779510789 @default.
• W2942881430 cites W2896693913 @default.
• W2942881430 cites W2902271181 @default.
• W2942881430 doi "https://doi.org/10.1371/journal.pmed.1002794" @default.
• W2942881430 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6490892" @default.
• W2942881430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31039166" @default.
• W2942881430 hasPublicationYear "2019" @default.
• W2942881430 type Work @default.
• W2942881430 sameAs 2942881430 @default.
• W2942881430 citedByCount "44" @default.
• W2942881430 countsByYear W29428814302019 @default.
• W2942881430 countsByYear W29428814302020 @default.
• W2942881430 countsByYear W29428814302021 @default.
• W2942881430 countsByYear W29428814302022 @default.
• W2942881430 countsByYear W29428814302023 @default.
• W2942881430 crossrefType "journal-article" @default.
• W2942881430 hasAuthorship W2942881430A5008722114 @default.
• W2942881430 hasAuthorship W2942881430A5014662243 @default.
• W2942881430 hasAuthorship W2942881430A5018647179 @default.
• W2942881430 hasAuthorship W2942881430A5022367224 @default.
• W2942881430 hasAuthorship W2942881430A5029873317 @default.
• W2942881430 hasAuthorship W2942881430A5045341602 @default.
• W2942881430 hasAuthorship W2942881430A5062721329 @default.
• W2942881430 hasAuthorship W2942881430A5066953701 @default.
• W2942881430 hasAuthorship W2942881430A5068234468 @default.
• W2942881430 hasAuthorship W2942881430A5071641093 @default.
• W2942881430 hasAuthorship W2942881430A5087168986 @default.
• W2942881430 hasAuthorship W2942881430A5090314881 @default.
• W2942881430 hasBestOaLocation W29428814301 @default.
• W2942881430 hasConcept C104317684 @default.
• W2942881430 hasConcept C114851261 @default.
• W2942881430 hasConcept C141231307 @default.
• W2942881430 hasConcept C142724271 @default.
• W2942881430 hasConcept C24432333 @default.
• W2942881430 hasConcept C2777107064 @default.
• W2942881430 hasConcept C2777975735 @default.
• W2942881430 hasConcept C2780035454 @default.
• W2942881430 hasConcept C2781069245 @default.
• W2942881430 hasConcept C51679486 @default.
• W2942881430 hasConcept C54355233 @default.
• W2942881430 hasConcept C70721500 @default.
• W2942881430 hasConcept C71924100 @default.
• W2942881430 hasConcept C86803240 @default.
• W2942881430 hasConcept C98274493 @default.
• W2942881430 hasConceptScore W2942881430C104317684 @default.
• W2942881430 hasConceptScore W2942881430C114851261 @default.
• W2942881430 hasConceptScore W2942881430C141231307 @default.
• W2942881430 hasConceptScore W2942881430C142724271 @default.
• W2942881430 hasConceptScore W2942881430C24432333 @default.
• W2942881430 hasConceptScore W2942881430C2777107064 @default.
• W2942881430 hasConceptScore W2942881430C2777975735 @default.
• W2942881430 hasConceptScore W2942881430C2780035454 @default.
• W2942881430 hasConceptScore W2942881430C2781069245 @default.
• W2942881430 hasConceptScore W2942881430C51679486 @default.
• W2942881430 hasConceptScore W2942881430C54355233 @default.
• W2942881430 hasConceptScore W2942881430C70721500 @default.
• W2942881430 hasConceptScore W2942881430C71924100 @default.
• W2942881430 hasConceptScore W2942881430C86803240 @default.
• W2942881430 hasConceptScore W2942881430C98274493 @default.
• W2942881430 hasFunder F4320320432 @default.
• W2942881430 hasIssue "4" @default.
• W2942881430 hasLocation W29428814301 @default.
• W2942881430 hasLocation W29428814302 @default.
• W2942881430 hasLocation W29428814303 @default.
• W2942881430 hasOpenAccess W2942881430 @default.
• W2942881430 hasPrimaryLocation W29428814301 @default.
• W2942881430 hasRelatedWork W1983144055 @default.
• W2942881430 hasRelatedWork W2069945100 @default.
• W2942881430 hasRelatedWork W2127258416 @default.
• W2942881430 hasRelatedWork W2355728116 @default.
• W2942881430 hasRelatedWork W2765996518 @default.
• W2942881430 hasRelatedWork W2906870439 @default.
• W2942881430 hasRelatedWork W3005252851 @default.
• W2942881430 hasRelatedWork W3141580208 @default.

• next